Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression

BACKGROUND: To evaluate the anatomic site(s) of initial disease progression in patients with castration resistant metastatic prostate cancer (mCRPC) in the presence or absence of pre-treatment visceral metastases while on systemic therapy. METHODS: This is a retrospective cohort study of mCRPC patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruchalski, Kathleen, Kim, Hyun J., Douek, Michael, Raman, Steven, Patel, Maitraya, Sai, Victor, Gutierrez, Antonio, Levine, Benjamin, Fischer, Cheryce, Allen-Auerbach, Martin, Gupta, Pawan, Coy, Heidi, Villegas, Bianca, Brown, Matthew, Goldin, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281063/
https://www.ncbi.nlm.nih.gov/pubmed/35836271
http://dx.doi.org/10.1186/s40644-022-00469-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281063/
https://www.ncbi.nlm.nih.gov/pubmed/35836271
http://dx.doi.org/10.1186/s40644-022-00469-z

Ejemplares similares